Healthy
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People who meet inclusion criteria 1) to 7) listed below and meet none of the exclusion criteria will be enrolled in the increasing order of the measured moisture content in the stratum corneum, with a target of 44 subjects with the lowest moisture content in the stratum corneum. Inclusion criteria: 1) Subjects who were willing to participate in the study and, after receiving an explanation of the study, who provided voluntary consent to participate in the study. 2) Healthy Japanese women aged between 20 years and less than 60 years who meet none of the exclusion criteria 3) Subjects who can complete documents such as a consent form and journal form 4) Subjects who can provide responses to an Internet-based questionnaire 5) Subjects who can visit the designated facility on the day of measurement 6) Subjects who have slight-to-mild facial dryness and scaly skin on the face or have a history of atopic dermatitis, which is in remission at the time of screening, and have facial dryness. 7) Self-perception of having sensitive skin
Exclusion criteria
Exclusion criteria: 1)Subjects who have a facial injury 2)Those who used a medicinal product that can potentially affect the study within 3 months of the start of the study or who will probably use a drug that can potentially affect the results during the study period 3)Subjects who underwent a cosmetic procedure such as collagen or hyaluronic acid injection, botox injection, chemical peeling, laser therapy, or phototherapy within 6 months of the start of the study or who will probably undergo one of the above-mentioned cosmetic procedures during the study period 4)Those currently receiving hormone replacement therapy or who will probably receive hormone replacement therapy during the study period 5)Those who will probably experience substantial exposure to sunlight during the study 6)Those who have previously developed serious skin problems arising from the use of cosmetic products or other similar products 7)Those who have previously developed dermatitis due to adhesive tape or other similar products 8)Subjects whose face is affected by atopic dermatitis or another skin disease 9)Those who suffer from severe hay fever 10)Those who habitually consume excess amounts of alcohol 11)Those who are unable to discontinue drugs that can potentially affect the study results 12)Those who have a history of severe liver disease, kidney disease, myocardial infarction, or other similar serious conditions and who will probably start to receive a new treatment at a medical institution during the study period 13)Those who suffer from severe anemia 14)Those who are pregnant or will potentially become pregnant during the study or who are breast-feeding 15)Those who will have participated in another clinical study between 3 months before screening and the end of this study or will probably participate in another clinical study during this study period 16)Subjects whose enrollment in the study is considered inappropriate by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Evaluation of improvement in cutaneous findings and dryness/scaly skin 2) Frequency of side effects | — |
Secondary
| Measure | Time frame |
|---|---|
| Instrumental measurements 1) Water content of stratum corneum 2) Transepidermal water loss | — |
Countries
Japan
Contacts
Beauty & Health Research Inc. Clinical Research Division